Benmoxin

Benmoxin
Clinical data
Routes of; administration	Oral
ATC code	None;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name N'-(1-phenylethyl)benzohydrazide;
CAS Number	7654-03-7 ;
PubChem CID	71671;
ChemSpider	64728 ;
UNII	XC9FY2SGBG;
ChEMBL	ChEMBL1877495 ;
CompTox Dashboard (EPA)	DTXSID0046220 ;
ECHA InfoCard	100.028.745
Chemical and physical data
Formula	C15H16N2O
Molar mass	240.306 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(NNC(c1ccccc1)C)c2ccccc2;
	InChI InChI=1S/C15H16N2O/c1-12(13-8-4-2-5-9-13)16-17-15(18)14-10-6-3-7-11-14/h2-12,16H,1H3,(H,17,18) ; Key:BEWNZPMDJIGBED-UHFFFAOYSA-N ;
	(what is this?) (verify)

Benmoxin (trade names Neuralex, Nerusil), also known as mebamoxine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class.^[1]^[2] It was synthesized in 1967 and was subsequently used as an antidepressant in Europe, but is now no longer marketed.^[1]^[2]

References

1 2 Ganellin CR, Triggle DJ (1996). Dictionary of Pharmacological Agents. Vol. 1–2. Chapman & Hall. p. 229. ISBN 0-9630096-0-5.
1 2 Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.

This drug article relating to the nervous system is a stub. You can help Wikipedia by adding missing information.